| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/25/2001 | WO2001036452A2 Heteroclitic analogs of class i epitodes |
| 05/25/2001 | WO2001036436A1 Gallotannins and ellagitannins as regulators of cytokine release |
| 05/25/2001 | WO2001036425A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 05/25/2001 | WO2001036419A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 05/25/2001 | WO2001036416A1 Novel thiazolidinedione derivatives as antidiabetic agents |
| 05/25/2001 | WO2001036408A1 Compounds with antibacterial and antiparasitic properties |
| 05/25/2001 | WO2001036396A1 Use of benzotriazole uv absorbers |
| 05/25/2001 | WO2001036395A1 Triazoles as farnesyl transferase inhibitors |
| 05/25/2001 | WO2001036391A1 Thiamin disulfide derivatives |
| 05/25/2001 | WO2001035999A1 Stable amorphous amifostine composition, and preparation thereof |
| 05/25/2001 | WO2001035998A1 Compositions for transdermal and transmucosal administration of therapeutic agents |
| 05/25/2001 | WO2001035994A2 Chitosan induced immunopotentiation |
| 05/25/2001 | WO2001035993A2 Compositions and methods for stimulating an immune response against infectious agents |
| 05/25/2001 | WO2001035992A1 Recombinant chlamydia vaccine |
| 05/25/2001 | WO2001035991A2 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 05/25/2001 | WO2001035987A1 An aqueous solution formulation of alpha-interferon |
| 05/25/2001 | WO2001035980A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 05/25/2001 | WO2001035964A1 Substituted 1-benzazepines and derivatives thereof |
| 05/25/2001 | WO2001035943A2 Dextrose and insulin fluid formulation for intravenous infusion |
| 05/25/2001 | WO2001035899A2 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 05/25/2001 | WO2001018005A8 Process for the preparation of benzoxazine derivatives and intermediates therefor |
| 05/25/2001 | WO2001007433A3 Quinoline derivatives and their use as antibacterial agents |
| 05/25/2001 | WO2001007432A3 Aminopiperidine derivatives as antibacterials |
| 05/25/2001 | WO2001000232A3 Use of cpg as an adjuvant for hiv vaccine |
| 05/25/2001 | WO2000078330A3 Adenosine diphosphatase and activators thereof and their medical uses |
| 05/25/2001 | WO2000067793A8 Death domain containing receptor 4 |
| 05/25/2001 | WO2000021558A9 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 05/25/2001 | WO2000010582A8 Probiotic, lactic acid-producing bacteria and uses thereof |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392094A1 Antisense oligonucleotide sequences derived from groel and groes as inhibitors of microorganisms |
| 05/25/2001 | CA2392076A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | CA2392059A1 Gallotannins and ellagitannins as regulators of cytokine release |
| 05/25/2001 | CA2391913A1 Novel thiazolidinedione derivatives as antidiabetic agents |
| 05/25/2001 | CA2391889A1 An aqueous solution formulation of alpha-interferon |
| 05/25/2001 | CA2391651A1 Protein c derivatives |
| 05/25/2001 | CA2391498A1 Substituted 1-benzazepines and derivatives thereof |
| 05/25/2001 | CA2391418A1 Stable amorphous amifostine composition, and preparation thereof |
| 05/25/2001 | CA2391403A1 Novel protein and dna thereof |
| 05/25/2001 | CA2391087A1 Imidazole compounds as phosphodiesterase vii inhibitors |
| 05/25/2001 | CA2390031A1 Double-stranded rna receptor (dsrna-r) and methods relating thereto |
| 05/25/2001 | CA2389851A1 Human igm antibodies to chemokine receptors |
| 05/25/2001 | CA2387809A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 05/25/2001 | CA2386341A1 Heteroclitic analogs and related methods |
| 05/24/2001 | US20010001711 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/23/2001 | EP1101769A2 Nitrogen Containing Erythromycin Derivatives |
| 05/23/2001 | EP1101766A1 Novel carbapenem derivatives |
| 05/23/2001 | EP1100950A1 Gastrointestinal bacterial antibody factories |
| 05/23/2001 | EP1100947A1 Method for the production of an antibiotic agent |
| 05/23/2001 | EP1100942A2 Herpes virus vectors for dendritic cells |
| 05/23/2001 | EP1100934A1 Herpesvirus preparations and their uses |
| 05/23/2001 | EP1100926A1 TRIMER OF HIV $i(ENV) GENE EXPRESSION PRODUCT |
| 05/23/2001 | EP1100922A1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 05/23/2001 | EP1100921A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/23/2001 | EP1100920A2 Nucleic acids and proteins from group b streptococcus |
| 05/23/2001 | EP1100918A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/23/2001 | EP1100917A1 Granulocytic ehrlichia genes and uses thereof |
| 05/23/2001 | EP1100916A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100910A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
| 05/23/2001 | EP1100908A2 Human receptor-associated proteins |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100902A1 Keratinocyte derived interferon |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100879A1 Pneumococcal nrdg protein |
| 05/23/2001 | EP1100878A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 05/23/2001 | EP1100869A1 98 human secreted proteins |
| 05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
| 05/23/2001 | EP1100818A1 Inhibitors of hiv membrane fusion |
| 05/23/2001 | EP1100814A2 Inhibitors of urokinase and blood vessel formation |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100807A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 05/23/2001 | EP1100802A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF |
| 05/23/2001 | EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 05/23/2001 | EP1100800A1 Novel c-2 s/o- and s/n formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and beta-lactamase inhibitors |
| 05/23/2001 | EP1100792A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 05/23/2001 | EP1100786A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 05/23/2001 | EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases |
| 05/23/2001 | EP1100548A2 Genetically engineered cells and tissues |
| 05/23/2001 | EP1100545A1 Regulated expression of recombinant proteins using rna viruses |
| 05/23/2001 | EP1100537A2 Multivalent human-bovine rotavirus vaccine |
| 05/23/2001 | EP1100536A2 Live attenuated salmonella vaccines to control avian pathogens |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/23/2001 | EP1100525A2 Modulation of apoptosis |
| 05/23/2001 | EP1100524A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 05/23/2001 | EP1100518A1 COMPOSITION AND METHOD OF TREATING DISEASE WITH EXTRACT OF $i(MUSACEAS) |
| 05/23/2001 | EP1100510A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
| 05/23/2001 | EP1100506A1 Integrin receptor antagonists |
| 05/23/2001 | EP1100493A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100492A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100468A1 Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| 05/23/2001 | EP1100464A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| 05/23/2001 | EP1100461A2 Method of vaccination of newly hatched poultry |
| 05/23/2001 | EP0683784B1 7,42-bis (o-demethyl) rapamycin |
| 05/23/2001 | EP0669827B1 Compositions for the regulation of cytokine activity |
| 05/23/2001 | EP0631578B1 Itraconazole and saperconazole stereoisomers |
| 05/23/2001 | EP0623170B1 Vaccines based on streptokinase |
| 05/23/2001 | EP0572433B1 Antigen-presenting capsid with fusion ms2-coat protein |